Aug 10, 2023 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the NATCO Pharma Limited Q1 FY '24 Earnings Conference Call hosted by Nuvama Wealth Management. (Operator Instructions) Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Kunal Randeria from Nuvama Wealth Management. Thank you, and over to you, sir.
Kunal Randeria - Nuvama Wealth Management Limited, Research Division - Research Analyst
Thank you, Karen, and good morning, everyone. On behalf of Nuvama Group, I welcome all for NATCO Pharma's Q1 FY '24 earnings Call. With us, we have NATCO Pharma's senior management team, represented by Mr. Rajeev Nannapaneni, Director and Chief Executive Officer; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences.
Over to you, Rajesh for open remarks.
Rajesh Chebiyam - NATCO Pharma Limited - EVP of Crop Health Sciences
Yeah. Thank you, Kunal. Good morning, and welcome, everyone, to NATCO's conference call discussing our earnings results for the first quarter
Q1 2024 Natco Pharma Ltd Earnings Call Transcript
Aug 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers